TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 2 | 2 | 3 | 4 | -2 | 17 | 7 | 5 |
P | %wins | 100 | 50 | 100 | 50 | 50 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/23/13 16:54 | 8/23/13 | VRX | Valeant Pharmaceuticals International, Inc. | A8 | Health | Drug | Pharmaceutical Preparations | Chai-Onn Robert Roswell | A8 | O | EVP,GC,C | P | 500 | 99.30 | 33 | 5 | 3 | 188 | D | 150 | 89 | 51 | 33 | 7 | 3 | -5 | -2 | 0 | -1 | 4 | 7 | 47 | 18 |
6/1/11 18:46 | 5/27/11 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Chai-Onn Robert Roswell | A6 | O | EVP,GC,C | P | 508 | 50.76 | 33 | 10 | 6 | 168 | D | 338 | 274 | 105 | 32 | -1 | -2 | 5 | 5 | 4 | 6 | 4 | -11 | -13 | -5 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |